bp... the Ovation PR mentioned an advisory panel in Jan.
"We are excited about how well ATryn is progressing through the regulatory process and are particularly pleased that FDA has accepted the filing for review," said Jeffrey S. Aronin, OVATION President and Chief Executive Officer. "This is a key milestone that paves the way for FDA to consider its approval early next year following the Blood Products Advisory Committee meeting in January."
I have not heard of a firm date for this meeting. Perhaps one place to check would be FDA site.
The creation of a thousand forests is in one acorn.
So far I see Dec 11-12, 2008 is the only date available for this year.
Advisory Committee Information Line: 1-800-741-8138 or 301-443-0572. Use the Blood Products Advisory Committee's 10-digit number -- 3014519516 -- when accessing the information line.
Information on Current and Past Meetings
2008
May 1-2, 2008 September 10-11, 2008 December 11-12, 2008 2008 Briefing Materials, Transcripts and Other Meeting Information